Addex Therapeutics
ADXN----
Addex Therapeutics (ADXN)
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company foc...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Addex Therapeutics Analyst Rating
View moreForecast & Rating
Oct 2, 2024Price forecast
$30.00903.34%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article ·
12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga_article ·
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- PUBT ·
Addex Therapeutics appoints Jean-Philippe Rocher head of pharmaceutical development
- Tip Ranks ·
Addex Therapeutics Earnings Call Highlights Pipeline Upside
